|
Index of reports
> Serious Events (1770)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ribavirin serious events. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 1770 Next >>
Possible Ribavirin side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient: female
Reactions: Cardiac Failure Congestive
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Indication: Hepatitis C
Start date: 2007-11-15
End date: 2008-10-01
Pegasys
Indication: Hepatitis C
Start date: 2007-11-15
End date: 2008-10-01
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: male, weighing 81.6 kg (179.6 pounds)
Reactions: Fatigue, Dizziness, Vision Blurred, Feeling Abnormal, Blood Glucose Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Incivek
Dosage: 750 mg, tid
Administration route: Oral
Start date: 2012-08-12
Ribavirin
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-14
End date: 2012-08-12
Ribavirin
Dosage: unk
Administration route: Oral
Start date: 2012-08-12
Pegasys
Dosage: 180 unk, unk
Start date: 2012-08-12
Pegasys
Dosage: 180 unk, unk
Indication: Hepatitis C
Start date: 2012-07-14
End date: 2012-08-03
Incivek
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-14
End date: 2012-08-10
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: male, weighing 90.7 kg (199.5 pounds)
Reactions: Fatigue, Wrist Fracture, Diarrhoea, Liver Function Test Abnormal, Anaemia, Haemorrhoids, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: 1000 mg, bid
Administration route: Oral
Indication: Hepatitis C
End date: 2012-07-01
VX-950
Dosage: unk
Administration route: Oral
VX-950
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-07-01
End date: 2011-10-01
Pegasys
Dosage: 180 unk, unk
Indication: Hepatitis C
End date: 2012-07-01
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female, weighing 83.0 kg (182.6 pounds)
Reactions: Tongue Ulceration, Thermoanaesthesia, Rash Pruritic, Oral Discomfort, Fatigue, Cough, Vomiting, Nausea, Haemorrhoids, Hypoaesthesia, Cognitive Disorder, Aptyalism, Anal Fissure, Anxiety, Throat Irritation, Diarrhoea, Dehydration, Insomnia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Incivek
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-27
End date: 2012-08-04
Pegasys
Dosage: 180 unk, unk
Indication: Hepatitis C
Start date: 2012-07-27
End date: 2012-08-04
Ribavirin
Dosage: 600 mg, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-27
End date: 2012-08-04
Possible Ribavirin side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Anaemia
Drug(s) suspected as cause:
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-02-08
PEG-Intron
Dosage: 1.5 ?g/kg, qw
Indication: Hepatitis C
Ribavirin
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
End date: 2012-02-07
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-04
Other drugs received by patient: Lorfenamin; Livalo; Epadel S; Claritin Reditabs; Sodium Ferrous Citrate
Possible Ribavirin side effects in male
Reported by a health professional (non-physician/pharmacist) from China on 2012-08-27
Patient: male, weighing 61.5 kg (135.3 pounds)
Reactions: Occult Blood, Anaemia, Faeces Discoloured
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2009-02-01
End date: 2009-04-07
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2008-08-01
End date: 2009-04-07
Other drugs received by patient: Sirolimus
Possible Ribavirin side effects in male
Reported by a pharmacist from United States on 2012-08-27
Patient: male, weighing 79.0 kg (173.8 pounds)
Reactions: Swelling Face, Neutropenia, Rash Pruritic
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Incivek
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-01
Pegasys
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-01
Ribavirin
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-01
Possible Ribavirin side effects in male
Reported by a physician from France on 2012-08-27
Patient: male, weighing 71.0 kg (156.2 pounds)
Reactions: Neutropenia
Drug(s) suspected as cause:
Ribavirin
Indication: Hepatitis C
VX-950
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Peginterferon Alfa-2A
Indication: Hepatitis C
Other drugs received by patient: Dexeryl
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: , weighing 117.9 kg (259.4 pounds)
Reactions: Abscess Rupture, Peritonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Incivek
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-07-18
End date: 2012-08-01
Incivek
Dosage: 750 mg, tid
Administration route: Oral
Start date: 2012-01-20
End date: 2012-05-18
Ribavirin
Dosage: unk
Indication: Hepatitis C
Start date: 2011-07-18
End date: 2012-05-18
Pegasys
Dosage: 180 a?g, unk
Indication: Hepatitis C
Start date: 2011-07-18
End date: 2012-05-18
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Dehydration, Anaemia, Lower Respiratory Tract Inflammation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
VX-950
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-15
Ribavirin
Dosage: unk
Indication: Hepatitis C
Start date: 2012-02-15
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-02-15
Possible Ribavirin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: HIP Arthroplasty
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Simvastatin
Simvastatin
Ribavirin
Simvastatin
Blinded Narlaprevir
Simvastatin
Blinded Boceprevir
Simvastatin
Simvastatin
Peginterferon Alfa-2B
Placebo
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: male
Reactions: Drug Ineffective, Diabetes Mellitus, Urinary Tract Infection, Musculoskeletal Stiffness, Diabetic Complication, Influenza Like Illness
Drug(s) suspected as cause:
Pegasys
Indication: Product Used FOR Unknown Indication
Start date: 2006-02-08
End date: 2006-06-16
Ribavirin
Indication: Product Used FOR Unknown Indication
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: male
Reactions: Night Sweats, Body Temperature Increased, Anaemia, Ascites, Dysgeusia, Insomnia, Blood Uric Acid Increased, Oedema Peripheral, Sinusitis
Drug(s) suspected as cause:
Ribavirin
Dosage: 400 mg, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-20
VX-950
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-20
End date: 2012-02-12
Pegasys
Dosage: 180 a?g, unk
Indication: Hepatitis C
Start date: 2011-11-20
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Loss of Consciousness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: 600 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-23
VX-950
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-23
Pegasys
Dosage: 180 unk, unk
Indication: Hepatitis C
Start date: 2012-07-23
Possible Ribavirin side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Anaemia, Rash, Haemolytic Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-03-16
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-24
End date: 2012-05-21
Ribavirin
Dosage: 500 mg, qd
Administration route: Oral
Start date: 2012-05-22
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-03-21
End date: 2012-04-03
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-03-16
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-02-27
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-02-28
End date: 2012-03-17
Ribavirin
Dosage: 300 mg, qd
Administration route: Oral
Start date: 2012-04-04
End date: 2012-04-23
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-03-15
Other drugs received by patient: Coniel; Famotidine; Allopurinol; Celestamine (Betamethasone (+) Dexchlorpheniramine Maleate (+) Fluphen; Isosorbide Dinitrate
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from Brazil on 2012-08-27
Patient:
Reactions: Breast Pain, Viral Load Increased, Varicose Vein Ruptured, Drug Ineffective, Pyrexia, Hypoaesthesia, Gynaecomastia, Malaise, Overdose, Swelling, Alopecia, Oedema Peripheral, Sensitivity of Teeth, Fluid Retention
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: unk, bid
Administration route: Oral
Start date: 2012-04-01
End date: 2012-06-18
Victrelis
Dosage: unk, tid
Administration route: Oral
Start date: 2012-04-01
End date: 2012-06-18
Ribavirin
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2005-01-01
End date: 2005-01-01
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-18
End date: 2012-04-01
Ribavirin
Dosage: unk
Administration route: Oral
Start date: 2011-12-01
End date: 2012-04-01
Other drugs received by patient: Coumadin; Coumadin; Pegasys; Lansoprazole; Pegasys; Pegasys
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from Russian Federation on 2012-08-27
Patient: female
Reactions: Tooth Extraction, Oedema, Dental Care
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2011-08-16
End date: 2012-06-29
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-16
End date: 2012-06-29
Other drugs received by patient: Tmc435
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: male, weighing 90.6 kg (199.3 pounds)
Reactions: Rash, Sensorimotor Disorder
Drug(s) suspected as cause:
Investigational Drug (Unspecified)
Dosage: 2 df, qd
Administration route: Oral
Start date: 2012-01-19
End date: 2012-03-13
Ribavirin
Dosage: 600 mg, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-29
End date: 2012-01-18
Placebo
Dosage: 1 df, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-29
End date: 2012-01-18
GS-5885
Dosage: 3 df, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-29
End date: 2012-01-18
Investigational Drug (Unspecified)
Dosage: 2 df, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-29
End date: 2012-01-18
Ribavirin
Dosage: 600 mg, bid
Administration route: Oral
Start date: 2011-01-19
End date: 2012-03-13
GS-5885
Dosage: 3 df, qd
Administration route: Oral
Start date: 2012-01-19
End date: 2012-03-13
Peginterferon Alfa-2A
Dosage: 180 microgram, qw
Indication: Hepatitis C
Start date: 2012-01-19
End date: 2012-03-09
Other drugs received by patient: Metoprolol Tartrate; Celexa; Codeine Sulfate; Sulindac; Zithromax; Tylenol; Aspirin; Ranitidine
Possible Ribavirin side effects in female
Reported by a physician from United States on 2012-08-27
Patient: female
Reactions: Abscess Limb
Drug(s) suspected as cause:
Interferon
Indication: Hepatitis C
Incivek
Administration route: Oral
Indication: Hepatitis C
Ribavirin
Indication: Hepatitis C
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-25
Patient: female
Reactions: Cholelithiasis, Weight Decreased, Peroneal Nerve Palsy, Fear, Transfusion, Asthenia, Myocardial Infarction, Blood Test Abnormal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Indication: Hepatitis C
Start date: 2011-09-16
Pegasys
Indication: Hepatitis C
Start date: 2011-09-16
End date: 2012-06-27
Victrelis
Indication: Hepatitis C
End date: 2012-06-27
Ribavirin
End date: 2012-06-27
Possible Ribavirin side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24
Patient: 67 year old female
Reactions: Nausea, Anaemia, Platelet Count Decreased, Blood Creatinine Increased, Hyperuricaemia, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.94 a?g/kg, unk
Start date: 2012-04-06
End date: 2012-04-26
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-03-16
End date: 2012-04-19
VX-950
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-03-23
End date: 2012-04-13
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-02-24
End date: 2012-03-15
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-20
End date: 2012-08-02
PEG-Intron
Dosage: 1.3 a?g/kg, unk
Start date: 2012-03-30
VX-950
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-02-24
End date: 2012-03-22
PEG-Intron
Dosage: 1.13 a?g/kg, unk
Start date: 2012-04-27
End date: 2012-05-10
VX-950
Dosage: 2250 mg, qd
Indication: Hepatitis C
Start date: 2012-02-17
End date: 2012-02-23
Ribavirin
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-17
End date: 2012-02-23
PEG-Intron
Dosage: 1.3 a?g/kg, unk
Start date: 2012-05-11
End date: 2012-08-02
PEG-Intron
Dosage: 1.5 a?g/kg, unk
Indication: Hepatitis C
Start date: 2012-02-17
End date: 2012-03-29
PEG-Intron
Start date: 2012-05-11
Other drugs received by patient: Diovan; Urso / 00465701 /; Innolet; Amlodipine
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient:
Reactions: White Blood Cell Count Decreased, Dyspnoea, Pruritus Generalised, Fatigue, Dysphonia, Depressed Mood, RED Blood Cell Count Abnormal, Cough
Drug(s) suspected as cause:
Victrelis
Dosage: 4 df, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-01
Pegasys
Dosage: 180 microgram, unk
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 200 mg, tid
Ribavirin
Dosage: 1000 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Pravastatin Sodium; Ambien; Prozac; Vitamin D; Trazodone HCL; Cholecalciferol; Levoxyl; Epoetin Alfa; Neupogen
Possible Ribavirin side effects in female
Reported by a pharmacist from United States on 2012-08-24
Patient: female
Reactions: Incoherent, RED Blood Cell Count Decreased, Faecal Incontinence, Fall
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Dosage: 90 mcg qw sq
Indication: Hepatitis C
Start date: 2012-05-30
Ribavirin
Dosage: 400mg bid po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-30
Other drugs received by patient: Incivek
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient: male
Reactions: Hepatitis, Liver Transplant
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Indication: Hepatitis C
End date: 2006-01-01
Interferon
Indication: Hepatitis C
End date: 2006-01-01
Possible Ribavirin side effects in female
Reported by a physician from United States on 2012-08-24
Patient: female
Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous, Pregnancy
Drug(s) suspected as cause:
Ribavirin
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from Spain on 2012-08-24
Patient:
Reactions: Neutropenic Colitis, Caecitis
Drug(s) suspected as cause:
Ribavirin
Indication: Hepatic Cirrhosis
Ribavirin
Dosage: 1200 mg, qd
Indication: Hepatitis C
Start date: 2011-12-01
Boceprevir
Indication: Hepatic Cirrhosis
Boceprevir
Dosage: 800 mg, tid
Indication: Hepatitis C
Start date: 2011-12-01
End date: 2011-12-01
Peginterferon Alfa-2A
Dosage: 180 ?g, qw
Start date: 2011-12-01
Possible Ribavirin side effects in 54 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24
Patient: 54 year old female
Reactions: Anxiety Disorder, Nausea, Insomnia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
VX-950
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-15
End date: 2012-02-21
VX-950
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-02-22
End date: 2012-05-08
PEG-Intron
Indication: Hepatitis C
Start date: 2012-02-15
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-15
End date: 2012-02-28
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-02-29
End date: 2012-06-12
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-13
End date: 2012-06-19
Ribavirin
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-06-20
End date: 2012-07-31
Other drugs received by patient: Ursodiol; Loxonin; Loxonin; Omeprazole; Januvia; Loxonin
Possible Ribavirin side effects in female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-24
Patient: female
Reactions: Back Pain, Oedema Peripheral, Headache
Drug(s) suspected as cause:
VX-950
Dosage: 750 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-01
End date: 2012-07-22
Ribavirin
Dosage: dosage form: unspecified
Indication: Hepatitis C
Start date: 2012-05-01
PEG-Intron
Dosage: dosage form: unspecified
Indication: Hepatitis C
Start date: 2012-05-01
Possible Ribavirin side effects in male
Reported by a pharmacist from United States on 2012-08-24
Patient: male
Reactions: Post Procedural Complication
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Dosage: 180mcg q week sq
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-07-10
Ribavirin
Dosage: 1000mg daily po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-07-10
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient: male, weighing 85.5 kg (188.0 pounds)
Reactions: Pemphigus, Stevens-Johnson Syndrome
Drug(s) suspected as cause:
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-25
End date: 2012-07-01
Incivek
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-25
End date: 2012-07-01
Pegasys
Indication: Hepatitis C
Start date: 2012-06-25
End date: 2012-07-01
Losartan Potassium
Dosage: 50 mg, qd
Administration route: Oral
Page 1 Next >>
|
